Tacrolimus news

All news on Tacrolimus (also known as FK506, Prograf, Advagraf, Astagraf XL, and Envarsus XR): plants, production capacities, investments and involved companies.

16 February 2026

Roche Reports Positive Phase III Results for Gazyva in Membranous Nephropathy

Phase III study shows Gazyva achieves higher remission rates in membranous nephropathy, with safety consistent and no new signals. Data to be shared with health authorities.
15 February 2026

Genentech's Gazyva Shows Positive Phase III Results in Primary Membranous Nephropathy

Phase III study shows Gazyva achieves significant remission in primary membranous nephropathy, with safety profile consistent and no new signals. Data to be shared with health authorities.

Who will be producing Tacrolimus in the future?

Find out with chemXplore Alpha

Learn more